Fujifilm Diosynth Biotechnologies has taken a significant step toward bolstering its microbial production capabilities with the inauguration of a new microbial fermentation manufacturing facility in Billingham, UK. As a leading contract development and manufacturing organization (CDMO), the company
Tanvex BioPharma USA, Inc., a frontrunner in biologics development, has made significant strides by securing FDA approval for NYPOZI (filgrastim-txid) and advancing its Biologics License Application (BLA) for TX-05. These milestones underscore the company’s unwavering commitment to delivering h
Novo Nordisk has announced a significant expansion of its manufacturing capabilities at its Køge site in Denmark, aiming to address the soaring global demand for its diabetes and obesity treatments. As one of the leading pharmaceutical companies worldwide, this move underlines Novo Nordisk's
US Specialty Formulations (USSF) has announced an ambitious $15 million expansion of its biopharma facility in Allentown, Pennsylvania. This initiative, highlighted in a July 31, 2024 press release, is aimed at significantly boosting the company's production capabilities and economic impact on
Global Automation in Biopharma Market to Surge by 2031: Key Trends and Forecasts The global biopharma market is on the cusp of remarkable transformations driven by automation, enabling more efficient production processes and improved product quality. This evolving sector is undergoing significant
Rentschler Biopharma, a renowned contract development and manufacturing organization (CDMO), has recently made significant strides in expanding its facilities and operational capabilities. Located in Milford, Massachusetts, the new addition emphasizes the company's dedication to the burgeoning
